{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:09:24Z","timestamp":1747181364799,"version":"3.33.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1007\/s11926-007-0052-8","type":"journal-article","created":{"date-parts":[[2007,8,23]],"date-time":"2007-08-23T03:51:28Z","timestamp":1187841088000},"page":"328-335","source":"Crossref","is-referenced-by-count":13,"title":["Small-vessel vasculitis: Therapeutic management"],"prefix":"10.1007","volume":"9","author":[{"given":"Carol A.","family":"Langford","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,8,24]]},"reference":[{"key":"52_CR1","doi-asserted-by":"crossref","first-page":"76","DOI":"10.7326\/0003-4819-98-1-76","volume":"98","author":"A. Fauci","year":"1983","unstructured":"Fauci A, Haynes B, Katz P, et al.: Wegener\u2019s granulomatosis: Prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 1983, 98:76\u201385.","journal-title":"Ann Intern Med"},{"key":"52_CR2","doi-asserted-by":"crossref","first-page":"488","DOI":"10.7326\/0003-4819-116-6-488","volume":"116","author":"G.S. Hoffman","year":"1992","unstructured":"Hoffman GS, Kerr GS, Leavitt RY, et al.: Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 1992, 116:488\u2013498.","journal-title":"Ann Intern Med"},{"key":"52_CR3","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/0002-9343(90)90367-M","volume":"89","author":"G.S. Hoffman","year":"1990","unstructured":"Hoffman GS, Leavitt RY, Fleisher TA, et al.: Treatment of Wegener\u2019s granulomatosis with intermittent high-dose intravenous cyclophosphamide. Am J Med 1990, 89:403\u2013410.","journal-title":"Am J Med"},{"key":"52_CR4","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1002\/art.1780401213","volume":"40","author":"L. Guillevin","year":"1997","unstructured":"Guillevin L, Cordier JF, Lhote F, et al.: A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegener\u2019s granulomatosis. Arthritis Rheum 1997, 40:2187\u20132198.","journal-title":"Arthritis Rheum"},{"key":"52_CR5","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1093\/ndt\/16.10.2018","volume":"16","author":"K. Groot de","year":"2001","unstructured":"de Groot K, Adu D, Savage CO, et al.: The value of pulse cyclophosphamide in ANCA-associated vasculitis: meta-analysis and critical review. Nephrol Dial Transplant 2001, 16:2018\u20132027.","journal-title":"Nephrol Dial Transplant"},{"key":"52_CR6","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1056\/NEJMoa020286","volume":"349","author":"D. Jayne","year":"2003","unstructured":"Jayne D, Rasmussen N, Andrassy K, et al.: A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med 2003, 349:36\u201344.","journal-title":"N Engl J Med"},{"key":"52_CR7","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s10067-004-1002-8","volume":"24","author":"E. Benenson","year":"2005","unstructured":"Benenson E, Fries JW, Heilig B, et al.: High-dose azathioprine pulse therapy as a new treatment option in patients with active Wegener\u2019s granulomatosis and lupus nephritis refractory or intolerant to cyclophosphamide. Clin Rheumatol 2005, 24:251\u2013257.","journal-title":"Clin Rheumatol"},{"key":"52_CR8","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0002-9343(03)00077-9","volume":"114","author":"C.A. Langford","year":"2003","unstructured":"Langford CA, Talar-Williams C, Barron KS, et al.: Use of a cyclophosphamide-induction methotrexate-maintenance regimen for the treatment of Wegener\u2019s granulomatosis: extended follow-up and rate of relapse. Am J Med 2003, 114:463\u2013469.","journal-title":"Am J Med"},{"key":"52_CR9","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1002\/1529-0131(199912)42:12<2666::AID-ANR24>3.0.CO;2-E","volume":"42","author":"C.A. Langford","year":"1999","unstructured":"Langford CA, Talar-Williams C, Barron KS, et al.: A staged approach to the treatment of Wegener\u2019s granulomatosis: induction of remission with glucocorticoids and daily cyclophosphamide switching to methotrexate for remission maintenance. Arthritis Rheum 1999, 42:2666\u20132673.","journal-title":"Arthritis Rheum"},{"key":"52_CR10","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/art.10459","volume":"47","author":"E. Reinhold-Keller","year":"2002","unstructured":"Reinhold-Keller E, Fink CO, Herlyn K, et al.: High rate of renal relapse in 71 patients with Wegener\u2019s granulomatosis under maintenance of remission with low-dose methotrexate. Arthritis Rheum 2002, 47:326\u2013332.","journal-title":"Arthritis Rheum"},{"key":"52_CR11","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/art.1780380505","volume":"38","author":"M. Sneller","year":"1995","unstructured":"Sneller M, Hoffman G, Talar-Williams C, et al.: Analysis of 42 Wegener\u2019s granulomatosis patients treated with methotrexate and prednisone. Arthritis Rheum 1995, 38:608\u2013613.","journal-title":"Arthritis Rheum"},{"key":"52_CR12","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1002\/art.21142","volume":"52","author":"K. Groot De","year":"2005","unstructured":"De Groot K, Rasmussen N, Bacon PA, et al.: Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 2005, 52:2461\u20132469.","journal-title":"Arthritis Rheum"},{"key":"52_CR13","doi-asserted-by":"crossref","first-page":"683","DOI":"10.7326\/0003-4819-143-9-200511010-00012","volume":"143","author":"G.S. Hoffman","year":"2005","unstructured":"Hoffman GS, Langford CA: Are there different forms of life in the antineutrophil cytoplasmic antibody universe? Ann Intern Med 2005, 143:683\u2013685.","journal-title":"Ann Intern Med"},{"key":"52_CR14","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1681\/ASN.V1091965","volume":"10","author":"R. Nowack","year":"1999","unstructured":"Nowack R, G\u00f6bel U, Klooker P, et al.: Mycophenolate mofetil for maintenance therapy of Wegener\u2019s granulomatosis and microscopic polyangiitis: a pilot study in 11 patients with renal involvement. J Am Soc Nephrol 1999, 10:1965\u20131971.","journal-title":"J Am Soc Nephrol"},{"key":"52_CR15","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/art.20240","volume":"51","author":"C.A. Langford","year":"2004","unstructured":"Langford CA, Talar-Williams C, Sneller MC: Mycophenolate mofetil for remission maintenance in the treatment of Wegener\u2019s granulomatosis. Arthritis Rheum 2004, 51:278\u2013283.","journal-title":"Arthritis Rheum"},{"key":"52_CR16","doi-asserted-by":"crossref","first-page":"c100","DOI":"10.1159\/000089667","volume":"102","author":"M. Koukoulaki","year":"2006","unstructured":"Koukoulaki M, Jayne DR: Mycophenolate mofetil in anti-neutrophil cytoplasm antibodies-associated systemic vasculitis. Nephron Clin Pract 2006, 102:c100\u2013107.","journal-title":"Nephron Clin Pract"},{"key":"52_CR17","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1093\/ndt\/gfi117","volume":"20","author":"M.S. Joy","year":"2005","unstructured":"Joy MS, Hogan SL, Jennette JC, et al.: A pilot study using mycophenolate mofetil in relapsing or resistant ANCA small vessel vasculitis. Nephrol Dial Transplant 2005, 20:2725\u20132732.","journal-title":"Nephrol Dial Transplant"},{"key":"52_CR18","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1136\/ard.2006.060301","volume":"66","author":"P.M. Stassen","year":"2007","unstructured":"Stassen PM, Cohen Tervaert JW, Stegeman CA: Induction of remission in active anti-neutrophil cytoplasmic antibody-associated vasculitis with mycophenolate mofetil in patients who cannot be treated with cyclophosphamide. Ann Rheum Dis 2007, 66:798\u2013802.","journal-title":"Ann Rheum Dis"},{"key":"52_CR19","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/rheumatology\/keh009","volume":"43","author":"C. Metzler","year":"2004","unstructured":"Metzler C, Fink C, Lamprecht P, et al.: Maintenance of remission with leflunomide in Wegener\u2019s granulomatosis. Rheumatology (Oxford) 2004, 43:315\u2013320.","journal-title":"Rheumatology (Oxford)"},{"issue":"Suppl3","key":"52_CR20","first-page":"262","volume":"64","author":"C. Metzler","year":"2005","unstructured":"Metzler C, Wagner-Bastmeyer R, Gross W, et al.: Leflunomide versus methotrexate for maintenance of remission in Wegener\u2019s granulomatosis-unexpected high relapse rate under oral methotrexate. Ann Rheum Dis 2005, 64(Suppl 3):262.","journal-title":"Ann Rheum Dis"},{"key":"52_CR21","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/qjmed\/93.7.433","volume":"93","author":"D.R. Jayne","year":"2000","unstructured":"Jayne DR, Chapel H, Adu D, et al.: Intravenous immunoglobulin for ANCA-associated systemic vasculitis with persistent disease activity. QJM 2000, 93:433\u2013439.","journal-title":"QJM"},{"key":"52_CR22","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0049-0172(86)90020-X","volume":"15","author":"P.J. Clements","year":"1986","unstructured":"Clements PJ, Davis J: Cytotoxic drugs: their clinical application to the rheumatic diseases. Sem Arth Rheum 1986, 15:231\u2013254.","journal-title":"Sem Arth Rheum"},{"key":"52_CR23","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/978-1-4757-9182-2_85","volume":"336","author":"N.B. Allen","year":"1993","unstructured":"Allen NB, Caldwell DS, Rice JR, et al.: Cyclosporin A therapy for Wegener\u2019s granulomatosis. Adv Exp Med Biol 1993, 336:473\u2013476.","journal-title":"Adv Exp Med Biol"},{"key":"52_CR24","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1111\/j.1523-1755.2004.00534.x","volume":"65","author":"W.H. Schmitt","year":"2004","unstructured":"Schmitt WH, Hagen EC, Neumann I, et al.: Treatment of refractory Wegener\u2019s granulomatosis with antithymocyte globulin (ATG): an open study in 15 patients. Kidney Int 2004, 65:1440\u20131448.","journal-title":"Kidney Int"},{"key":"52_CR25","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1093\/ndt\/gfi070","volume":"21","author":"R. Birck","year":"2006","unstructured":"Birck R, Newman M, Braun C, et al.: 15-Deoxyspergualin and cyclophosphamide, but not mycophenolatemofetil, prolong survival and attenuate renal disease in a murine model of ANCA-associated crescentic nephritis. Nephrol Dial Transplant 2006, 21:58\u201363.","journal-title":"Nephrol Dial Transplant"},{"key":"52_CR26","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0025-6196(12)65279-3","volume":"60","author":"R.A. DeRemee","year":"1985","unstructured":"DeRemee RA, McDonald TJ, Weiland LH: Wegener\u2019s granulomatosis: observations on treatment with antimicrobial agents. Mayo Clin Proc 1985, 60:27\u201332.","journal-title":"Mayo Clin Proc"},{"key":"52_CR27","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1056\/NEJM199607043350103","volume":"335","author":"C.A. Stegeman","year":"1996","unstructured":"Stegeman CA, Cohen Tervaert JW, de Jong PE, et al.: Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener\u2019s granulomatosis. N Engl J Med 1996, 335:16\u201320.","journal-title":"N Engl J Med"},{"key":"52_CR28","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1053\/j.ajkd.2003.08.015","volume":"42","author":"P.J. Klemmer","year":"2003","unstructured":"Klemmer PJ, Chalermskulrat W, Reif MS, et al.: Plasmapheresis therapy for diffuse alveolar hemorrhage in patients with small-vessel vasculitis. Am J Kidney Dis 2003, 42:1149\u20131153.","journal-title":"Am J Kidney Dis"},{"key":"52_CR29","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1002\/art.1780391020","volume":"39","author":"C.A. Langford","year":"1996","unstructured":"Langford CA, Sneller MC, Hallahan CW, et al.: Clinical features and therapeutic management of subglottic stenosis in patients with Wegener\u2019s granulomatosis. Arthritis Rheum 1996, 39:1754\u20131760.","journal-title":"Arthritis Rheum"},{"key":"52_CR30","first-page":"1017","volume":"30","author":"G.S. Hoffman","year":"2003","unstructured":"Hoffman GS, Thomas-Golbanov CK, Chan J, et al.: Treatment of subglottic stenosis, due to Wegener\u2019s granulomatosis, with intralesional corticosteroids and dilation. J Rheumatol 2003, 30:1017\u20131021.","journal-title":"J Rheumatol"},{"key":"52_CR31","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1056\/NEJMoa041884","volume":"352","author":"Wegener\u2019s Granulomatosis Etanercept Trial Research Group","year":"2005","unstructured":"Wegener\u2019s Granulomatosis Etanercept Trial Research Group: Etanercept plus standard therapy for Wegener\u2019s granulomatosis. N Engl J Med 2005, 352:351\u2013361.","journal-title":"N Engl J Med"},{"key":"52_CR32","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1002\/art.21869","volume":"54","author":"J.H. Stone","year":"2006","unstructured":"Stone JH, Holbrook JT, Marriott MA, et al.: Solid malignancies among patients in the Wegener\u2019s Granulomatosis Etanercept Trial. Arthritis Rheum 2006, 54:1608\u20131618.","journal-title":"Arthritis Rheum"},{"issue":"Suppl4","key":"52_CR33","doi-asserted-by":"crossref","first-page":"iv31","DOI":"10.1136\/ard.2005.042416","volume":"64","author":"C. Mukhtyar","year":"2005","unstructured":"Mukhtyar C, Luqmani R: Current state of tumour necrosis factor alpha blockade in Wegener\u2019s granulomatosis. Ann Rheum Dis 2005, 64(Suppl 4):iv31\u201336.","journal-title":"Ann Rheum Dis"},{"key":"52_CR34","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1517\/14712598.7.4.521","volume":"7","author":"P.M. Aries","year":"2007","unstructured":"Aries PM, Lamprecht P, Gross WL: Biological therapies: new treatment options for ANCA-associated vasculitis? Expert Opin Biol Ther 2007, 7:521\u2013533.","journal-title":"Expert Opin Biol Ther"},{"key":"52_CR35","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1097\/01.ASN.0000114554.67106.28","volume":"15","author":"A. Booth","year":"2004","unstructured":"Booth A, Harper L, Hammad T, et al.: Prospective study of TNFalpha blockade with infliximab in anti-neutrophil cytoplasmic antibody-associated systemic vasculitis. J Am Soc Nephrol 2004, 15:717\u2013721.","journal-title":"J Am Soc Nephrol"},{"key":"52_CR36","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1002\/1529-0131(200112)44:12<2836::AID-ART471>3.0.CO;2-W","volume":"44","author":"U. Specks","year":"2001","unstructured":"Specks U, Fervenza FC, McDonald TJ, et al.: Response of Wegener\u2019s granulomatosis to anti-CD20 chimeric monoclonal antibody therapy. Arthritis Rheum 2001, 44:2836\u20132840.","journal-title":"Arthritis Rheum"},{"key":"52_CR37","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/art.20718","volume":"52","author":"K.A. Keogh","year":"2005","unstructured":"Keogh KA, Wylam ME, Stone JH, et al.: Induction of remission by B lymphocyte depletion in eleven patients with refractory antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 2005, 52:262\u2013268.","journal-title":"Arthritis Rheum"},{"key":"52_CR38","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1164\/rccm.200507-1144OC","volume":"173","author":"K.A. Keogh","year":"2006","unstructured":"Keogh KA, Ytterberg SR, Fervenza FC, et al.: Rituximab for refractory Wegener\u2019s granulomatosis: report of a prospective, open-label pilot trial. Am J Respir Crit Care Med 2006, 173:180\u2013187.","journal-title":"Am J Respir Crit Care Med"},{"key":"52_CR39","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1365-2796.2005.01494.x","volume":"257","author":"P. Eriksson","year":"2005","unstructured":"Eriksson P: Nine patients with anti-neutrophil cytoplasmic antibody-positive vasculitis successfully treated with rituximab. J Intern Med 2005, 257:540\u2013548.","journal-title":"J Intern Med"},{"key":"52_CR40","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1093\/rheumatology\/kel098","volume":"45","author":"R. Stasi","year":"2006","unstructured":"Stasi R, Stipa E, Del Poeta G, et al.: Long-term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab. Rheumatology (Oxford) 2006, 45:1432\u20131436.","journal-title":"Rheumatology (Oxford)"},{"key":"52_CR41","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1080\/02813430510015269","volume":"34","author":"R. Omdal","year":"2005","unstructured":"Omdal R, Wildhagen K, Hansen T, et al.: Anti-CD20 therapy of treatment-resistant Wegener\u2019s granulomatosis: favourable but temporary response. Scand J Rheumatol 2005, 34:229\u2013232.","journal-title":"Scand J Rheumatol"},{"key":"52_CR42","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1136\/ard.2005.044420","volume":"65","author":"P.M. Aries","year":"2006","unstructured":"Aries PM, Hellmich B, Voswinkel J, et al.: Lack of efficacy of rituximab in Wegener\u2019s granulomatosis with refractory granulomatous manifestations. Ann Rheum Dis 2006, 65:853\u2013858.","journal-title":"Ann Rheum Dis"},{"key":"52_CR43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.20717","volume":"52","author":"M.C. Sneller","year":"2005","unstructured":"Sneller MC: Rituximab and Wegener\u2019s granulomatosis: are B cells a target in vasculitis treatment? Arthritis Rheum 2005, 52:1\u20135.","journal-title":"Arthritis Rheum"},{"key":"52_CR44","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/00005792-199901000-00003","volume":"78","author":"L. Guillevin","year":"1999","unstructured":"Guillevin L, Cohen P, Gayraud M, et al.: Churg-Strauss syndrome. Clinical study and long-term follow-up of 96 patients. Medicine (Baltimore) 1999, 78:26\u201337.","journal-title":"Medicine (Baltimore)"},{"key":"52_CR45","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/1529-0131(200103)44:3<666::AID-ANR116>3.0.CO;2-A","volume":"44","author":"M. Gayraud","year":"2001","unstructured":"Gayraud M, Guillevin L, le Toumelin P, et al.: Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: analysis of four prospective trials including 278 patients. Arthritis Rheum 2001, 44:666\u2013675.","journal-title":"Arthritis Rheum"},{"key":"52_CR46","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/BOR.0b013e3280119854","volume":"19","author":"C. Pagnoux","year":"2007","unstructured":"Pagnoux C, Guilpain P, Guillevin L: Churg-Strauss syndrome. Curr Opin Rheumatol 2007, 19:25\u201332.","journal-title":"Curr Opin Rheumatol"},{"issue":"6Suppl36","key":"52_CR47","first-page":"S52","volume":"22","author":"C. Metzler","year":"2004","unstructured":"Metzler C, Hellmich B, Gause A, et al.: Churg Strauss syndrome\u2014successful induction of remission with methotrexate and unexpected high cardiac and pulmonary relapse ratio during maintenance treatment. Clin Exp Rheumatol 2004, 22(6 Suppl 36):S52\u2013S61.","journal-title":"Clin Exp Rheumatol"},{"key":"52_CR48","doi-asserted-by":"crossref","first-page":"370","DOI":"10.7326\/0003-4819-129-5-199809010-00004","volume":"129","author":"E. Tatsis","year":"1998","unstructured":"Tatsis E, Schnabel A, Gross WL: Interferon-alpha treatment of four patients with the Churg-Strauss syndrome. Ann Intern Med 1998, 129:370\u2013374.","journal-title":"Ann Intern Med"},{"key":"52_CR49","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1136\/ard.2004.032664","volume":"64","author":"C. Metzler","year":"2005","unstructured":"Metzler C, Lamprecht P, Hellmich B, et al.: Leucoencephalopathy after treatment of Churg-Strauss syndrome with interferon alpha. Ann Rheum Dis 2005, 64:1242\u20131243.","journal-title":"Ann Rheum Dis"},{"key":"52_CR50","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1136\/ard.2005.047308","volume":"65","author":"V.V. Kaushik","year":"2006","unstructured":"Kaushik VV, Reddy HV, Bucknall RC: Successful use of rituximab in a patient with recalcitrant Churg-Strauss syndrome. Ann Rheum Dis 2006, 65:1116\u20131117.","journal-title":"Ann Rheum Dis"},{"key":"52_CR51","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/ard.2005.042937","volume":"65","author":"M. Koukoulaki","year":"2006","unstructured":"Koukoulaki M, Smith KG, Jayne DR: Rituximab in Churg-Strauss syndrome. Ann Rheum Dis 2006, 65:557\u2013559.","journal-title":"Ann Rheum Dis"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-007-0052-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11926-007-0052-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-007-0052-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T14:58:47Z","timestamp":1737385127000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11926-007-0052-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":51,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["52"],"URL":"https:\/\/doi.org\/10.1007\/s11926-007-0052-8","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"type":"print","value":"1523-3774"},{"type":"electronic","value":"1534-6307"}],"subject":[],"published":{"date-parts":[[2007,8]]}}}